Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resveratrol for Polycystic Ovary Syndrome (PCOS)
IRCT2017061917139N2Phase 3Completed
- Sponsor
- GVK EMRI
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of resveratrol in polycystic ovary syndrome (PCOS), sponsored by GVK EMRI. Started Jul 2017; status: completed.
02
Drugs
resveratrol
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT2017061917139N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017061917139N2.